Shred Ultra Advanced Watermelon (Body Science International Pty Ltd)
Product Name
Shred Ultra Advanced Watermelon
ARTG
366755
Date of review outcome
Date of publication
Jun-2024
Outcome
Medicine continues to be permitted for supply
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification. However, use of this medicine may pose a safety risk for some people. Follow the recommended actions below.
What action should consumers take?
Seek advice from a suitably qualified health practitioner if you are or have been using this medicine to alleviate anxiety, improve insulin resistance or control blood sugar levels.
Consider whether this medicine is right for you based on it potentially not working as expected in relation to nootropic action, improving cognitive function, improving/increasing mental performance, concentration, focus and clarity, improving brain function, increasing physical performance, increasing muscle mass and strength, suppressing appetite, increasing metabolism and fat burning mechanisms, reducing/alleviating stress, boosting testosterone levels, reducing inflammation, reducing hunger and cravings, controlling metabolism, regulating calorie burning (affecting weight loss and weight gain), playing a role in DNA repair and improving blood capillary and vessel health.
Consider whether this medicine is right for you based on it potentially not working as expected in relation to nootropic action, improving cognitive function, improving/increasing mental performance, concentration, focus and clarity, improving brain function, increasing physical performance, increasing muscle mass and strength, suppressing appetite, increasing metabolism and fat burning mechanisms, reducing/alleviating stress, boosting testosterone levels, reducing inflammation, reducing hunger and cravings, controlling metabolism, regulating calorie burning (affecting weight loss and weight gain), playing a role in DNA repair and improving blood capillary and vessel health.
Review scope
Targeted
Information reviewed
ARTG Record, Website
Issues related to safety
The website for this medicine contained claims specified in 'What action should consumers take?' above. Some of these claims, and references to anxiety without specifying mild forms of the condition, are not permitted for listed medicines without prior evaluation or approval from the TGA. References to non-permitted claims have the potential to lead consumers to delay access to timely advice or treatment from a suitability qualified health professional when required, which may result in adverse outcomes.
While advertising of this nature is unacceptable, these claims have been removed from the website and the website advised consumers to consult a health professional if experiencing unwanted symptoms. As such, this medicine is unlikely to pose an immediate risk to consumer health and safety.
While advertising of this nature is unacceptable, these claims have been removed from the website and the website advised consumers to consult a health professional if experiencing unwanted symptoms. As such, this medicine is unlikely to pose an immediate risk to consumer health and safety.
Issues related to efficacy
The website for this medicine contained claims specified in 'What action should consumers take?' above. However, these claims were not covered by the sponsor's certification that they held evidence to substantiate them.
Actions taken during the review
The TGA required the sponsor to correct the issues with this medicine. The sponsor updated the website to correct the issues.